FIELD: pharmacology.
SUBSTANCE: invention relates to the use of a peptide having the formula Thr-Lys-Pro-Arg-Pro-Gly-Pro (selank), for hepatoprotective effects in chronic emotional-pain stress.
EFFECT: increased effectiveness of treatment of diseases with chronic pain syndrome.
1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF PEPTIDE Thr-Lys-Pro-Arg-Pro-Gly-Pro (SELANC) HEPATOPROTECTIVE FOR EXPOSURE IN ACUTE IMMOBILISATION STRESS | 2015 |
|
RU2582963C1 |
| APPLICATION OF Thr-Lys-Pro-Arg-Pro-Gly-Pro PEPTIDE (SELANK) FOR TOXIC HEPATITIS PREVENTION AND TREATMENT | 2017 |
|
RU2640133C1 |
| APPLICATION OF PEPTIDE Thr-Lys-Pro-Arg-Pro-Gly-Pro (SELANG) FOR DYSBIOSIS CORRECTION UNDER CHRONIC IMMOBILIZATION STRESS | 2018 |
|
RU2681217C1 |
| USE OF THE PEPTIDE Thr-Lys-Pro-Arg-Pro-Gly-Pro (SELANK) TO INCREASE BODY RESISTANCE TO ACUTE HYPOTHERMIA | 2019 |
|
RU2709503C1 |
| METHOD FOR PREVENTING AND TREATING ULCERS OF GASTRO-INTESTINAL TRACT | 2003 |
|
RU2252779C1 |
| AGENT POSSESSING ANTI-COAGULATING, ANTI-THROMBOCYTIC, ANTI-THROMBOSIS, FIBRIN-DEPOLYMERIZING AND FIBRINOLYTIC ACTIVITY | 2005 |
|
RU2290195C1 |
| APPLICATION OF THE HIS-PHE-ARG-TRP-PRO-GLY-PRO PEPTIDE FOR THE PREVENTION OF DYSBIOSIS IN CHRONIC IMMOBILIZATION STRESS | 2021 |
|
RU2770583C1 |
| ANXIOLYTIC AGENT AND PHARMACEUTICAL COMPOSITION WITH ANXIOLYTIC EFFECT | 1999 |
|
RU2155065C1 |
| USING DELTA-SLEEP INDUCING PEPTIDE FOR HEPATOPROTECTIVE ACTION IN CHRONIC EMOTIONAL PAIN STRESS | 2013 |
|
RU2537032C2 |
| USE OF PEPTIDE ACTH (4-7) -PGP OF HEPATOPROTECTIVE ACTION | 2013 |
|
RU2528741C1 |
